唑来膦酸对耐紫杉烷、雌莫司汀、卡铂和地塞米松的转移性激素难治性前列腺癌的作用。
Effect of zoledronic acid on metastatic hormone-refractory prostate cancer resistant to taxane, estramustine, carboplatin, and dexamethasone.
作者信息
Kikuno Nobuyuki, Urakami Shinji, Nakamura Shigeru, Shiina Hiroaki, Igawa Mikio
机构信息
Department of Urology, Shimane University School of Medicine, Izumo, Japan.
出版信息
Int J Urol. 2007 Jan;14(1):82-4. doi: 10.1111/j.1442-2042.2006.01566.x.
Abstract
This case report demonstrates the effect of zoledronic acid (ZA) on a patient with bone metastatic hormone-refractory prostate cancer (HRPC) resistant to taxane, estramustine phosphate, carboplatin, and dexamethasone. The pathogenesis, diagnosis, and management of bone metastasis on HRPC are also reviewed.
摘要
本病例报告展示了唑来膦酸（ZA）对一名患有骨转移性激素难治性前列腺癌（HRPC）患者的疗效，该患者对紫杉烷、磷酸雌莫司汀、卡铂和地塞米松耐药。本文还回顾了HRPC骨转移的发病机制、诊断和治疗。
Zotero 插件